ARCHIVES

Large, Conclusive Trials Provide Answers To Treatment Questions For GI Cancers

This article is from The Cancer Letter archive.

Vol. 32 No. 6 | June 26, 2009

Download PDF Visit The Full Archive

Related Articles

FDA Grants Orphan Designation To E7777 in T-Cell Lymphoma

August 30, 2013

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

April 22, 2005

Bypass Budget Going to White House Next Month Will Seek Optimal Funding for Cancer Program

August 22, 1980

In Brief: NCI Grants Get More Money, Pay Line Boosted To 193

May 22, 1981

Niccotine Reports As Aiding Metastasis

August 22, 1986

Economic Analyses Of New Therapies Useful In Phase III Studies, Trialists Say

July 24, 2009